Healthtech Startups
17,201 companies tagged Healthtech, with their investors and founders.
0 investors
0 investors
0 investors
Gravitas Medical develops the Entarik Feeding Tube System, a medical device that assists in feeding tube placement and continuously monitors tube position using bio-impedance sensors and safety alerts. The system is designed for healthcare facilities and ICU nurses managing enteral nutrition for patients unable to feed orally.
0 investors
GrayHawk Health provides in-home and virtual medical care combined with individual health coaching for high-risk, older community members, coordinating clinical, social, and behavioral health needs. It works through at-risk, collaborative partnerships with health benefits providers to improve member engagement, health outcomes, and medical cost management.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Greenlight offers a platform for collecting and integrating health data from consumer wearables, EHRs, and third-party systems, with automated workflows, dashboards, and AI capabilities. It serves healthcare, life sciences, research, and insurance organizations for patient engagement and data collection.
0 investors
0 investors
Greenwich LifeSciences is a clinical-stage biopharmaceutical company developing GP2, a peptide immunotherapy targeting the HER2/neu protein, aimed at preventing breast cancer recurrence. It is running Flamingo-01, a global Phase III trial evaluating its GLSI-100 candidate in HER2/neu positive breast cancer patients.
0 investors
0 investors
Greyledge Technologies develops diagnostic and cell-analysis equipment and services for regenerative medicine practitioners to characterize biologic treatments like PRP and stem cell therapies. The company works with physicians and biotech providers to enable precise cell quantification and FDA-compliant cellular therapy delivery.
0 investors
0 investors
GRIP Molecular Technologies develops a diagnostic platform built on a CRISPR protease engine that detects pathogen RNA (bacteria, viruses, fungi) from saliva, swab, and urine samples with molecular-grade accuracy in minutes at ambient temperature. It targets point-of-care and point-of-need testing for sexually transmitted, urinary tract, and upper respiratory infections, adaptable to lateral flow, electrochemical, and colorimetric readouts.
0 investors
0 investors
0 investors